1. Scrip
  2. >>Partnered Content

Infographic: Advancing Drug Development in Oncology

Infographic
ICON Biotech FP

Citeline and ICON Biotech surveyed over 100 professionals to uncover their key pain points in the oncology drug development lifecycle, capturing the key challenges and future advancements hoping to accelerate patient treatments.

Explore a snapshot of key findings from the survey, including:

  • Current therapies in the oncology pipeline
  • Clinical vs therapeutic development challenges
  • Latest strategies accelerating drug development
  • The role of AI/ML in advancing R&D
  • Emerging trends and predictions

Download the infographic: Advancing Drug Development in Oncology

More from Partnered Content

More from Scrip

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.